货号:A749538
同义名:
(S)-(+)-氯吡格雷硫酸盐
/ (S)-(+)-Clopidogrel hydrogen sulfate; (S)-(+)-Clopidogrel bisulfate
Clopidogrel hydrogen sulfate是一种通过抑制CYP2B6和CYP2C19防止血栓形成的抗血小板药物,IC50分别为18.2 nM和524 nM。它是一种高效的抗血栓药物,抑制ADP诱导的血小板聚集,也是口服活性的P2Y(12)抑制剂。
There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
靶点 |
|
描述 | Clopidogrel hydrogen sulfate is an antiplatelet agent which works by blocking platelets from sticking together and prevents them from forming harmful clots. Clopidogrel abolishes the inhibitory P2Y(AC) receptor-mediated ADP effects on prostaglandin E(1)-stimulated, cAMP-dependent phosphorylation of VASP (vasodilator-stimulated phosphoprotein) without affecting epinephrine, thrombin, and thromboxane signaling[3]. The inhibitory effect of clopidogrel on platelet consumption by the growing thrombi resulted apparently in higher platelet concentration at the collagen surface, which enhanced the platelet-collagen adhesion at all three shear rates[4]. Clopidogrel therapy resulted in a significant reduction in soluble CD40 ligand (P = 0.03), a prothrombotic and proinflammatory molecule derived mainly from activated platelets[5]. Clopidogrel (clopi) is a prodrug widely prescribed in the management of coronary artery disease and requires the intervention of hepatic cytochrome P450 2C19 (CYP2C19) for its activation[6]. Resistance to clopidogrel is largely a result of CYP2C19 enzyme loss of function alleles. One-year patency rates following lower extremity arterial endovascular interventions in patients with clopidogrel resistance (HPR) range between 35%-83% whereas those with the proper response to clopidogrel range between 73%-100%[7]. |
Concentration | Treated Time | Description | References | |
Bone marrow-derived macrophages (BMDMs) | 5 ng/mL | 5 days | To investigate the induction of P2Y12 expression by TGF-β1 in BMDMs, the results showed that TGF-β1 induced P2Y12 expression via a Smad3-dependent mechanism, and inhibition of P2Y12 could block MMT and collagen matrix production. | Mol Ther. 2022 Sep 7;30(9):3017-3033. |
Administration | Dosage | Frequency | Description | References | ||
Mice | Photothrombotic stroke model | Intraperitoneal injection | 40 mg/kg | Daily for 14 days | To evaluate the impact of clopidogrel on cognitive and motor function recovery post-stroke in mice. Results showed that clopidogrel significantly impaired learning and memory recovery, reduced mouse survival rates, and decreased body weight. Additionally, clopidogrel significantly increased vascular leakage, increased the number and altered the morphology of microglia, and reduced the number of T cells in the peri-infarct region post-stroke. | Int J Mol Sci. 2023 Jul 20;24(14):11706 |
C57BL/6J and IL-1R−/− mice | Diet-induced obesity model | Oral | 5 mg/kg | Single dose | To study the responsiveness of clopidogrel in diet-induced obese mice, results showed that wild-type DIO mice exhibited resistance to the anti-platelet and anti-thrombotic effects of clopidogrel, while IL-1R?/? DIO mice showed no resistance. | Arterioscler Thromb Vasc Biol. 2020 Jun;40(6):1533-1542 |
LysM-Cre/Rosa26-tdTomato mice | Unilateral ureteral obstruction (UUO) model | Oral | 60 mg/kg/day | Once daily for 7 days | To investigate the inhibitory effect of clopidogrel on renal fibrosis in UUO mice, the results showed that clopidogrel significantly inhibited renal fibrosis, P2Y12 expression, and TGF-β/Smad3 signaling pathway. | Mol Ther. 2022 Sep 7;30(9):3017-3033. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.38mL 0.48mL 0.24mL |
11.91mL 2.38mL 1.19mL |
23.82mL 4.76mL 2.38mL |
CAS号 | 120202-66-6 |
分子式 | C16H18ClNO6S2 |
分子量 | 419.9 |
SMILES Code | ClC1=C([C@@H](C(OC)=O)N2CCC3=C(C=CS3)C2)C=CC=C1.O=S(O)(O)=O |
MDL No. | MFCD00876395 |
别名 | (S)-(+)-氯吡格雷硫酸盐 ;(S)-(+)-Clopidogrel hydrogen sulfate; (S)-(+)-Clopidogrel bisulfate; SR 25990C; (S)-(+)-Clopidogrel (sulfate); Clopidogrel Bisulfate |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
溶解方案 |
DMSO: 45 mg/mL(107.17 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 15 mg/mL(35.72 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|